Importantly, although hepatocellular carcinoma (HCC) similarly exhibits glutamine addiction, GOT2 is lowly expressed in HCC cells, which is related to advanced progression and poor prognosis.33 This evidence concerns the gene GOT2 and hepatocellular carcinoma.